Species-specific differences in the glucocorticoid receptor transactivation function upon binding with betamethasone-esters

International Immunopharmacology

Volumn 2, Issue 7, 2002, Pages 941-950

  Tanigawa, Kiyoshi ^a   Nagase, Hideki ^a   Ohmori, Koichi ^a   Tanaka, Katsunao ^a   Miyake, Hidekazu ^a   Kiniwa, Mamoru ^a   Ikizawa, Koichi ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Dissociated glucocorticoid; Glucocorticoid receptor; Species difference; Transactivation; Transrepression

Indexed keywords

ANTIGEN; BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BECLOMETHASONE 17 PROPIONATE; BETAMETHASONE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; DEXAMETHASONE; DEXAMETHASONE 17,21 DIPROPIONATE; ESTER DERIVATIVE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; TYROSINE AMINOTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BINDING AFFINITY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENZYME INDUCTION; ESTERIFICATION; FEMALE; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; THYMUS DISEASE; TRANSACTIVATION; WEIGHT REDUCTION;

ANIMALS; BETAMETHASONE; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTERS; FEMALE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; PROTEIN BINDING; RATS; RATS, INBRED BN; RECEPTORS, GLUCOCORTICOID; SPECIES SPECIFICITY; TRANS-ACTIVATION (GENETICS);

EID: 0036310206     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00036-X     Document Type: Article

References (39)

1. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms
2. Glucocorticoid therapy for immune-mediated diseases: Basic and clinical correlates
3. Efficacy and safety of inhaled corticosteroids. New developments
4. Molecular characterization of the glucocorticoid receptor
5. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor
6. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone
7. Interference between pathway-specific transcription factors: Glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo
8. DNA sequences bound specifically by glucocorticoid receptor in vitro render a heterologous promoter hormone responsive in vivo
9. Functional domains of the human glucocorticoid receptor
10. Synergistic action of the glucocorticoid receptor with transcription factors
11. Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element
12. Glucocorticoids are required for establishment and maintenance of an alteration in chromatin structure: Induction leads to a reversible disruption of nucleosomes over an enhancer
13. Cytokine modulation by glucocorticoids: Mechanisms and actions in cellular studies
14. Mechanism of gene expression by the glucocorticoid receptor: Role of protein-protein interactions
15. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1
16. Structure/function of the human glucocorticoid receptor: Tyrosine 735 is important for transactivation
17. Conformational change in the human glucocorticoid receptor induced by ligand binding is altered by mutation of isoleucine 747 by a threonine
18. DNA binding of the glucocorticoid receptor is not essential for survival
19. Molecular genetic dissection of glucocorticoid receptor function in vivo
20. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo
21. Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity
22. Vasoconstrictor and systemic activities of topical steroids
23. Adrenal hypertrophy produced by 17alpha-esterified glucocorticoids in rat foetus
24. Correlation between metabolism of betamethasone 17,21-dipropionate and adrenal hypertrophy in rat fetuses
25. Effects of dexamethasone 17-esters on adrenal weight and hydrolysis of glucocorticoid 17-esters in rat fetuses
26. Tyrosine aminotransferase (rat liver)
27. Nonsteroidal selective glucocorticoid modulators: The effect of C-5 alkyl substitution on the transcriptional activation/repression profile of 2,5-dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines
28. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression
29. Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown-Norway rats
30. Unlinked regulation of the sensitivity of primary glucocorticoid-inducible responses in mouse mammary tumor virus infected Fu5-5 rat hepatoma cells
31. Activation of beclomethasone dipropionate by hydrolysis to beclomethasone-17-monopropionate
32. Pharmacokinetics of butixocort 21-propionate, budesonide, and beclomethasone dipropionate in the rat after intratracheal, intravenous, and oral treatments
33. Decomposition of beclomethasone propionate esters in human plasma
34. Metabolism kinetics of beclomethasone propionate esters in human lung homogenates
35. Pharmacologic study of the glucocorticoid activity of flunisolide compared with other steroids in the rat
36. Novel glucocorticoid receptor coactivator effector mechanisms
37. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
38. Structure-activity relationships in glucocorticoid-induced apoptosis in T lymphocytes
39. Position 16 of the steroid nucleus modulates glucocorticoid-induced apoptosis at the transcriptional level in murine T-lymphocytes